Overview Financials News + Filings
|
| In millions, except per share items | Sep-30-20 | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues |
| Billing Services | 1.4 | 1.8 | 2.3 | 2.8 | 3.1 | 3.5 | 4.3 | 4.9 |
| OTC and Prescription Medicine | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 0.9 | 1.1 | 1.4 |
| |
| EBITDA |
| Billing Services | 1.3 | 1.5 | 1.8 | 2.2 | 2.2 | 2.3 | 2.6 | 2.7 |
| OTC and Prescription Medicine | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 |
| Corporate | -3.1 | -4.1 | -4.0 | -3.9 | -4.5 | -3.3 | -3.2 | -3.2 |
| |
| EBIT |
| Billing Services | 1.0 | 1.2 | 1.5 | 1.8 | 1.8 | 1.9 | 2.2 | 2.3 |
| OTC and Prescription Medicine | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Corporate | -3.1 | -4.1 | -4.0 | -3.9 | -4.5 | -3.3 | -3.2 | -3.2 |
| |
| Mix |
| Billing Services | 80.6% | 81.4% | 81.1% | 80.5% | 79.8% | 79.8% | 79.8% | 78.5% |
| OTC and Prescription Medicine | 19.4% | 18.6% | 18.9% | 19.5% | 20.2% | 20.2% | 20.2% | 21.5% |
| |
| Growth |
| Billing Services | -53.9% | -47.9% | -47.2% | -43.4% | | | | |
| OTC and Prescription Medicine | -56.2% | -53.0% | -51.5% | -50.1% | | | | |
|